Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms (Q46585287)
Jump to navigation
Jump to search
scientific article published in January 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms |
scientific article published in January 2005 |
Statements
1 reference
Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms (English)
1 reference
Quinn JE
1 reference
Brown LG
1 reference
Zhang J
1 reference
Keller ET
1 reference
Vessella RL
1 reference
Corey E
1 reference
1 January 2005
1 reference
8
1 reference
3
1 reference
253-259
1 reference
Identifiers
1 reference